Maxim Group Maintains Actinium(ATNM.US) With Buy Rating, Announces Target Price $5
Actinium Pharma Analyst Ratings
Stephens Maintains Actinium(ATNM.US) With Buy Rating, Cuts Target Price to $5
Actinium Pharma Analyst Ratings
H.C. Wainwright Maintains Actinium(ATNM.US) With Buy Rating, Cuts Target Price to $4
B. Riley Downgrades Actinium Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $2 From $16
Actinium Pharmaceuticals Price Target Cut to $4.00/Share From $50.00 by HC Wainwright & Co.
Maxim Group Maintains Actinium(ATNM.US) With Buy Rating
Actinium Pharma Analyst Ratings
Maxim Group Maintains Buy on Actinium Pharma, Lowers Price Target to $5
JonesTrading Maintains Actinium(ATNM.US) With Buy Rating, Cuts Target Price to $9
Actinium Pharmaceuticals Price Target Maintained With a $50.00/Share by HC Wainwright & Co.
Actinium Pharma Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target
H.C. Wainwright Maintains Actinium(ATNM.US) With Buy Rating, Maintains Target Price $50
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target
Actinium Pharma Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Citius Pharmaceuticals (CTXR), Actinium Pharmaceuticals (ATNM)
Actinium Pharma Analyst Ratings
Actinium Pharma Analyst Ratings